Paper37562003
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Leiding JW and 68 others. Blood, 2023. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Papers, record 37562003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37562003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Granulomatous Disease, Chronic | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Graft vs Host Disease | Major topic |
| Humans | |
| Retrospective Studies | |
| Prospective Studies | |
| Transplantation, Homologous | |
| Genotype | |
| Transplantation Conditioning |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 TR001263 | NCATS NIH HHS | United States | U01TR001263 | PubMed and NIH | NIH RePORTER |
| UL1 TR002494 | NCATS NIH HHS | United States | UL1TR002494 | PubMed and NIH | NIH RePORTER |
| U24 CA076518 | NCI NIH HHS | United States | U24CA076518 | PubMed and NIH | NIH RePORTER |
| U54 AI082973 | NIAID NIH HHS | United States | U54AI082973 | PubMed and NIH | NIH RePORTER |
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed | NIH RePORTER |
| KL2 TR002492 | NCATS NIH HHS | United States | KL2TR002492 | PubMed and NIH | NIH RePORTER |
| U01 HL069294 | NHLBI NIH HHS | United States | U01HL069294 | PubMed and NIH | NIH RePORTER |
| U54 NS064808 | NINDS NIH HHS | United States | U54NS064808 | PubMed and NIH | NIH RePORTER |
| ZIA AI001222 | Intramural NIH HHS | United States | ZIAAI001222 | PubMed | NIH RePORTER |
| Z01 AI000644 | Intramural NIH HHS | United States | ZIAAI000644 | PubMed and NIH | NIH RePORTER |
| U10 HL069254 | NHLBI NIH HHS | United States | U10HL069254 | PubMed and NIH | NIH RePORTER |
| R13 AI094943 | NIAID NIH HHS | United States | R13AI094943 | PubMed | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02082353 | Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 | Derived from the trial | Yes |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 38095925 | HCT alleviates disease burden in CGD. | https://conductscience.org/library/papers/38095925 |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25537876 | Common severe infections in chronic granulomatous disease. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25537876 | PubMed |
| 2 | 21190454 | Residual NADPH oxidase and survival in chronic granulomatous disease. | N Engl J Med | 2010 | https://conductscience.org/library/papers/21190454 | PubMed |
| 3 | 27543157 | A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease. | Biol Blood Marrow Transplant | 2016 | https://conductscience.org/library/papers/27543157 | PubMed |
| 4 | 7004534 | Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. | Blood | 1981 | https://conductscience.org/library/papers/7004534 | PubMed |
| 5 | 19222467 | Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. | Br J Haematol | 2009 | https://conductscience.org/library/papers/19222467 | PubMed |
| 6 | 7581076 | 1994 Consensus Conference on Acute GVHD Grading. | Bone Marrow Transplant | 1995 | https://conductscience.org/library/papers/7581076 | PubMed |
| 7 | 23011479 | Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant. | J Clin Immunol | 2013 | https://conductscience.org/library/papers/23011479 | PubMed |
| 8 | 28752258 | Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial. | J Clin Immunol | 2017 | https://conductscience.org/library/papers/28752258 | PubMed |
| 9 | 26644451 | Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT. | Blood | 2016 | https://conductscience.org/library/papers/26644451 | PubMed |
| 10 | 32801991 | Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease. | Pediatric Health Med Ther | 2020 | https://conductscience.org/library/papers/32801991 | PubMed |
| 11 | 31376032 | Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. | J Clin Immunol | 2019 | https://conductscience.org/library/papers/31376032 | PubMed |
| 12 | 32849547 | Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849547 | PubMed |
| 13 | 31228584 | Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/31228584 | PubMed |
| 14 | 34548626 | A prospective pilot study of a novel alemtuzumab target concentration intervention strategy. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/34548626 | PubMed |
| 15 | 35033700 | Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry. | J Allergy Clin Immunol Pract | 2022 | https://conductscience.org/library/papers/35033700 | PubMed |
| 16 | 32614953 | Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. | Blood | 2020 | https://conductscience.org/library/papers/32614953 | PubMed |
| 17 | 18037347 | Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. | Clin Immunol | 2008 | https://conductscience.org/library/papers/18037347 | PubMed |
| 18 | 10844935 | Chronic granulomatous disease. Report on a national registry of 368 patients. | Medicine (Baltimore) | 2000 | https://conductscience.org/library/papers/10844935 | PubMed |
| 19 | 18410635 | Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. | Clin Exp Immunol | 2008 | https://conductscience.org/library/papers/18410635 | PubMed |
| 20 | 29746679 | Noninfectious Manifestations and Complications of Chronic Granulomatous Disease. | J Pediatric Infect Dis Soc | 2018 | https://conductscience.org/library/papers/29746679 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42352030 | Molecular Views into the Synthesis and Activation of Flavocytochrome b558 in Phagocytic Cells-Focus on the Role of EROS. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42352030 | PubMed |
| 42170004 | How I Treat: Chronic granulomatous disease. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42170004 | PubMed |
| 42169994 | Hematopoietic stem cell transplantation following invasive mold infection in chronic granulomatous disease: Insights from a case series and literature review. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42169994 | PubMed |
| 41660618 | Atopy and immune dysregulation among patients with chronic granulomatous disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41660618 | PubMed |
| 41046057 | Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/41046057 | PubMed |
| 40278093 | Invasive Fungal Infection by Scedosporium apiospermum with Cerebral Involvement in a Pediatric Patient Affected by Chronic Granulomatous Disease After Hematopoietic Cell Transplant. | J Fungi (Basel) | 2025 | https://conductscience.org/library/papers/40278093 | PubMed |
| 40227295 | The Role of NADPH Oxidase 2 in Leukocytes. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40227295 | PubMed |
| 39746704 | [Refractory or resistant cytomegalovirus infections after hematopoietic stem cell transplantation: diagnosis and management]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | https://conductscience.org/library/papers/39746704 | PubMed |
| 39665712 | Implementation of a Pilot Study in Adolescent Health Care Transition Program for Chronic Granulomatous Disease: A Single Institution Experience. | J Pediatr Health Care | 2025 | https://conductscience.org/library/papers/39665712 | PubMed |
| 39496935 | Mold infections in chronic granulomatous disease patients-what comes to the rescue? | Bone Marrow Transplant | 2025 | https://conductscience.org/library/papers/39496935 | PubMed |
| 39332496 | Severe clinical phenotypes of heterozygous females with X-linked chronic granulomatous disease. | J Allergy Clin Immunol Pract | 2024 | https://conductscience.org/library/papers/39332496 | PubMed |
| 39278553 | High symptom burden in female X-linked chronic granulomatous disease carriers. | Clin Immunol | 2024 | https://conductscience.org/library/papers/39278553 | PubMed |
| 39005504 | Clinical presentation, diagnosis, and treatment of chronic granulomatous disease. | Front Pediatr | 2024 | https://conductscience.org/library/papers/39005504 | PubMed |
| 38429865 | Functional neutrophil disorders: Chronic granulomatous disease and beyond. | Immunol Rev | 2024 | https://conductscience.org/library/papers/38429865 | PubMed |
| 38290608 | Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study. | J Allergy Clin Immunol | 2024 | https://conductscience.org/library/papers/38290608 | PubMed |
| 37763024 | Haematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. | J Clin Med | 2023 | https://conductscience.org/library/papers/37763024 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37562003
GET https://conductscience.org/api/papers/v1/37562003/authors?page=2